Literature DB >> 26002020

[Diabetes, prediabetes and cardiovascular risk].

B Stratmann1, D Tschoepe.   

Abstract

Cardiovascular diseases continue to be the mainstay in morbidity and mortality in modern society with diabetes mellitus being a known risk factor for coronary artery disease, heart failure and vascular events. Most patients present with a combination of hypertension, dyslipoproteinaemia and (pre)diabetic metabolism potentiating the risk. From the perspective of organ damage two of three patients with coronary artery disease present with impaired glucose metabolism. In case of myocardial infarction 25-28% of patients do not present with impaired glucose metabolism. Women are more often affected than men and exhibit a more severe outcome, if diagnoses of vascular events and diabetes occur in parallel. Atrial fibrillation and heart failure are significantly associated with diabetes and significantly confer to the overall prognosis. Epidemiologically, the risk for vascular events is closely associated with the glucose burden of the affected patient.

Entities:  

Mesh:

Year:  2015        PMID: 26002020     DOI: 10.1007/s00108-015-3681-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  24 in total

1.  Lessons learned from the detection of ischemia in asymptomatic diabetics (DIAD) study.

Authors:  Frans J Th Wackers; Lawrence H Young
Journal:  J Nucl Cardiol       Date:  2009-08-15       Impact factor: 5.952

2.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

3.  Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.

Authors:  Joseph B Muhlestein; Donald L Lappé; Joao A C Lima; Boaz D Rosen; Heidi T May; Stacey Knight; David A Bluemke; Steven R Towner; Viet Le; Tami L Bair; Andrea L Vavere; Jeffrey L Anderson
Journal:  JAMA       Date:  2014-12-03       Impact factor: 56.272

4.  Glycemic control and heart failure among adult patients with diabetes.

Authors:  C Iribarren; A J Karter; A S Go; A Ferrara; J Y Liu; S Sidney; J V Selby
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

5.  Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study.

Authors:  R Doerr; U Hoffmann; W Otter; L Heinemann; W Hunger-Battefeld; B Kulzer; A Klinge; V Lodwig; I Amann-Zalan; D Sturm; D Tschoepe; S G Spitzer; J Stumpf; T Lohmann; O Schnell
Journal:  Diabetologia       Date:  2011-07-20       Impact factor: 10.122

Review 6.  [Diabetes and heart failure: a practically oriented critical appraisal].

Authors:  M Halle; A K Gitt; M Hanefeld; M Kellerer; N Marx; J J Meier; P-M Schumm-Draeger; P Bramlage; D Tschoepe
Journal:  Dtsch Med Wochenschr       Date:  2012-02-21       Impact factor: 0.628

7.  Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure.

Authors:  Ida Gustafsson; Bente Brendorp; Marie Seibaek; Hans Burchardt; Per Hildebrandt; Lars Køber; Christian Torp-Pedersen
Journal:  J Am Coll Cardiol       Date:  2004-03-03       Impact factor: 24.094

8.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

9.  Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.

Authors:  Peter D Reaven; Thomas E Moritz; Dawn C Schwenke; Robert J Anderson; Michael Criqui; Robert Detrano; Nicholas Emanuele; Moti Kayshap; Jennifer Marks; Sunder Mudaliar; R Harsha Rao; Jayendra H Shah; Steven Goldman; Domenic J Reda; Madeline McCarren; Carlos Abraira; William Duckworth
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

Review 10.  Insulin use early in the course of type 2 diabetes mellitus: the ORIGIN trial.

Authors:  Markolf Hanefeld; Peter Bramlage
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.